Pear Therapeutics, Inc. (PEAR): Price and Financial Metrics
GET POWR RATINGS... FREE!
PEAR Stock Price Chart Interactive Chart >
PEAR Price/Volume Stats
|Current price||$4.27||52-week high||$14.60|
|Prev. close||$3.59||52-week low||$2.81|
|Day high||$4.34||Avg. volume||334,327|
|50-day MA||$4.73||Dividend yield||N/A|
|200-day MA||$7.13||Market Cap||588.56M|
Pear Therapeutics, Inc. (PEAR) Company Bio
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
Most Popular Stories View All
PEAR Latest News Stream
|Loading, please wait...|
PEAR Latest Social Stream
View Full PEAR Social Stream
Latest PEAR News From Around the Web
Below are the latest news stories about Pear Therapeutics Inc that investors may wish to consider to help them evaluate PEAR as an investment opportunity.
Pear Therapeutics Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapy Inclusive of All of Its Commercial Products
BOSTON, February 24, 2022--Pear Therapeutics Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapy Inclusive of All of Its Commercial Products
BOSTON, February 17, 2022--Pear Therapeutics to Participate in Citi’s 2022 Virtual Healthcare Conference
BOSTON, February 15, 2022--Pear Therapeutics Announces Availability of reSET® and reSET-O® in Spanish
Pear Therapeutics Announces State of Michigan to Fund Access to Prescription Digital Therapeutics for Substance Use and Opioid Use Disorders
BOSTON, February 10, 2022--Pear Therapeutics Announces State of Michigan to Fund Access to Prescription Digital Therapeutics for Substance Use and Opioid Use Disorders
The stock markets have started off 2022 with increased volatility, and that’s opened up opportunities for investors – especially for investors willing to shoulder some additional risk. The sharp decline in January lowered prices, while the rapid swings we’ve seen in recent trading sessions makes it possible to take advantage of the lowered entry point. A market situation like this should naturally bring investors’ attention to the penny stocks. These low-cost equities, typically priced below $5 per share, are perfectly placed to bring the high-powered returns when markets move back to a bullish trend.
PEAR Price Returns